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ABSTRACT
Objective: To document the prevalence of malaria parasitaemia among the HIV infected 
febrile children in a malaria endemic area.
Design: A cross-sectional study.
Setting: An ambulatory paediatric HIV clinic in Western Kenya, between November 
2011 and December 2012.
Subjects: A total of 245 febrile HIV infected children aged less than 14 years attending 
the HIV clinic in the Webuye level IV hospital were included in the study. A systematic 
sampling method was used.
Main outcomes: A blood sample was taken for malaria parasite testing. Presence 
or absence of malaria parasites was documented. Clinical and socio-demographic 
characteristics of the participants were also recorded.
Results: A total of 245 participants were recruited mean age being 5.53 years. Malaria 
prevalence was 81.9%. Most participants (97%) were on cotrimoxazole prophylaxis. 
Some of the factors found to be positively associated with malaria parasitaemia were; 
male sex, care taker category (parent), WHO stage 3 and 4 of HIV disease, and a high 
absolute CD4 count. However, only the caretaker association was statistically significant.
Conclusion: The frequency of malaria parasitaemia among febrile HIV infected 
children is still high regardless of the high cotrimoxazole prophylaxis uptake. It is 
also noted that there is a shift in the age group of fever among children toward the 
older age group. This implies that policies may need to be relooked at to include the 
older age group in the aggressive malaria prevention measures to avoid losing on the 
already made gains.
INTRODUCTION
Fever is one of the most common reasons why parents 
bring their children to the outpatient setting of any 
health facility. The causes of fever in children in 
resource-limited settings, such as is in rural Kenyan 
health facilities, is rarely investigated; often diagnostic 
investigations are limited to the more readily available 
blood slide for malaria parasites and widal test 
(serology for Salmonella typhi ).  Even where these 
tests are available, clinicians often do not pursue 
them (1, 2)
Clinicians follow the Integrated Management of 
Common Childhood Illnesses (IMCI) protocol 
for fever management in addition to disease 
epidemiological pattern.  These factors might not 
however always apply especially to an HIV-infected 
child, who is not only at risk of atypical infections 
but also likely to have atypical presentation of illness 
due to immunosuppression (3).
 There is little data on common pathogens 
responsible for fever among HIV-infected children, 
especially in the context of cotrimoxazole use. 
Therefore, fever in HIV-infected children is commonly 
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managed in a similar manner like it is in HIV-
uninfected children.  This can result in inaccurate 
diagnosis, delay in proper management, and 
ultimately, serious morbidity and mortality.
 Malaria and HIV co- infection is common 
especially in sub-Saharan Africa.In Kenya malaria 
transmission rates vary from one area to the other 
with areas around the large water bodies having the 
highest and the cooler areas experiencing the least. 
Nearly half, (49%), of Kenyan population lie in high 
transmission areas though concentrated in a small 
area of Kenya. The areas in Western province are 
high Malaria regions. Kenya has an HIV prevalence 
rate of6.7% (4,).
	 The	effect	of	HIV	on	malaria	seems	not	to	have	
consensus especially in the paediatric population. 
Whilst in adults there seems to be clearer associations, 
in children there is scarce data (5).
 Generally HIV appears to increase the incidence 
of malaria in adults. However, not many studies have 
evaluated	this	effect	 in	children.	A	recent	study	in	
Tanzania (2012) provides the closest evidence to the 
effect	 that	HIV	infection	 is	a	risk	for	development	
of malaria (6). Villamor et al. had earlier in 2003 
concluded that among the children they studied, 
11.4% of HIV-infected versus 27.6% of HIV-uninfected 
developed malaria in the same country, Tanzania (7).
Malaria associated morbidities have been shown to 
be worse in children co-infected with HIV. In Kenya 
and Malawi among others, HIV has been associated 
with increased incidences of severe anaemia (5). 
Hendriksen  et.al showed that the prognosis of malaria 
in children with HIV was worse with 26% likely to 
die compared to 9% of those HIV-uninfected (3).
 While in adults worsening immunity(declining 
CD4) is associated with increased malaria attacks, 
current data from children living in malaria endemic 
regions  is limited and inconclusive (5,8). There 
has	also	been	no	demonstrated	difference	in	risk	of	
developing malaria among children when one is on 
ARVs (Antiretroviral) versus when not on ARVs (6). 
However, Akyalalshaku  et.al showed being on ARVS 
was protective, he however considered all age groups 
(8). 
 While breast feeding and use of cotrimoxazole 
were shown to be protective in Tanzania (6), a review 
published three years earlier, had pointed out that 
data	on	the	protective	effect	of	cotrimoxazole	on	HIV	
infected children on malaria is scarce. This is unlike 
the clear statement that cotrimoxazole protects against 
malaria in HIV-uninfected (5).
 WHO recommendation also state that 
confirmatory malaria test is necessary before 
starting children on anti-malarial contrary to the 
guidelines earlier on. However, the guidelines do not 
specifically	guide	on	the	management	of	febrile	HIV	
infected children in malaria endemic areas especially 
considering the already documented high morbidity 
and mortality in this population (3, 5). 
 It is also recommended that all children who are 
HIV infected should be on cotrimoxazole prophylaxis. 
This also is known to be protective against malaria 
(9, 10).  It is therefore expected that in a cohort of 
HIV infected children on cotrimoxazole the malaria 
burden should be low.
 We set out to determine the prevalence and 
describe the clinical and socio-demographic factors 
associated with malaria parasitaemia in a cohort 
of febrile HIV infected children with high uptake 
of cotrimoxazole prophylaxis in malaria –HIV co 
endemic area. This study serves as an eye opener to 
the	development	of	a	management	guideline	specific	
for febrile HIV infected children in malaria endemic 
zone where cotrimoxazole prophylaxis uptake is high. 
The study seeks to answer the question is malaria 
still a priority cause of fever among HIV-infected 
children in the context of prophylactic cotrimoxazole 
as standard of care in a malaria-endemic region.
MATERIALS AND METHODS
A cross-sectional study of HIV-infected children with 
acute fever was carried out in an ambulatory clinic in 
malaria –HIV co endemic region of western Kenya. 
 The study was conducted at a level IV health 
facility, Webuye District Hospital, in Bungoma East 
District, Western Kenya which serves as a referral 
centre to several health centers and dispensaries; 
Webuye is a malaria-endemic area with annual 
transmission ranging from 20-40%; HIV transmission 
rate is about 5.1%(4,).  The hospital houses one of the 
AMPATH (Academic Model for Providing Access 
to Healthcare) clinics, which serves HIV-infected 
children. AMPATH was founded in 2001 to address 
HIV/AIDS pandemic in Western Kenya; AMPATH 
now manages a cohort of over 22,000 HIV-infected or 
HIV-affected	children	in	more	than	fifty-five	clinical	
sites throughout the region.  All children diagnosed 
with HIV are put on cotrimoxazole prophylaxis and 
may be protected from common organisms that cause 
fever including malaria.
 Sample size was determined using Fischer’s 
formula	at	95%	confidence	level	and	a	standard	error	
of 5%. The estimated transmission rate among febrile 
children was estimated as is 17% from a study done 
in a Malaria endemic area in Kenya (11). This gave a 
minimum sample size of 217.
 The study recruited 245 febrile children 
(axillarytemperatures of >37.5 degree Celsius) below 
14	years	with	confirmed	HIV	infection	following	a	
consenting process with the parents or the guardian. 
Those children already on anti-malarial drugs or those 
with other obvious cause of fever were excluded.
 A local research nurse performed patient 
recruitment and consenting.   Data was collected by 
a trained research assistant and investigators and 
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stored on a password-protected study computer for 
subsequent analysis by co-investigators.  
 A peripheral venous blood sample was obtained 
from each child who met the eligibility criteria, and 
put into an EDTA bottle. This was used to prepare 
a thick blood smear which was then stained using 
Giemsa stain and examined under oil emersion power 
100 for malaria parasites.
 Two laboratory technicians examined the 
samples separately and a third one was used to resolve 
discrepancies for purpose of quality assurance.
 Data analysis was done using the STATA version 
10. Measures of central tendency were used to describe 
continuous variables while frequency tables were 
used for categorical data. Chi square and Kruskal 
Wallis test were used to test associations between the 
dependent and independent variable. All analysis 
was	done	at	95%	confidence	level.
 Consent was obtained from the guardian or 
the parent of these children before any data was 
taken and before the samples were taken. No names 
were used instead subject numbers were assigned 
to each participant. The blood slide results were 
communicated to the primary care giver as soon as it 
was possible. No information deemed useful for the 
patient management was withheld from the primary 
care giver. Approval to carry out the study was sought 
from all the necessary authorities including Institution 
Research Ethics Committee of Moi University/Moi 
Teaching and Referral Hospital.
RESULTS
A total of 245 participants were recruited into the 
study with a male female ratio of 1.35:1. The mean age 
of the participants was 5.53 years with a range of 0.3 
-12.78 years. Table 1 and 2 provides the characteristics 
of the study participants.
Table 1
Anthropometric and clinical characteristics of the study participants
Variable Mean(sd) Range
Weight(kg) 19.3 (7.39) 5-48
Temperature oC 38.5 (0.44) 37.5-40.2
Respiratory rate (/min) 37.9 (8.31) 22-68
Pulse rate (/min) 109.3(18.28) 76-196
CD4 count (absolute) 239.4(1261.18) 2-18360
Table 2
Socio-demographic characteristics of study participants
Variable Frequency(n) % of n
Sex Male 141 57.6%
Female 104 42.4%
Residence Bungoma East 136 55.5%
Outside Bungoma East 109 44.5%




Referrals Yes 47 19.18%
No 198 80.81%
Primary caretaker Parent 199 81.2%
Grandparent 12 4.9%
Others 30 12.2%
A total of 80.5% of all subjects were in WHO clinical stage 1 and 2 with only 0.8% being in stage 4.
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Figure 1
WHO clinical staging of HIV disease among the participants.
 
Most of the recruited participants were on 
cotrimoxazole prophylaxis for opportunistic 
infections (97%).
 Apart from fever the other common clinical 
presentations found were general malaise in 85.3% 
of the participants, joint pains in 75% and vomiting 
in 34.7 %.
 Malaria parasitaemia prevalence among the 
participants was found to be 81.9 %. Several clinical 
and socio-demographic factors were found to be 
positively associated with malaria parasitaemia 
among the febrile HIV infected children  example 
male sex, caretaker (parent),WHO stage 3 and 4 ,and a 
high absolute CD4 count. However, only the caretaker 
factor	was	found	to	be	statistically	significant.	Those	
children who had other persons or grandparents as 
care takers had  a lower  risk of malaria parasitaemia 
as compared to those who had a parent for a primary 
caretaker with an odd ratio and P-value of 0.164 (0.001) 
and 0.570 (0.520 ) respectively. Other persons in this 
case referred to children’s homes and guardian’s 
other than the grandparents (Table 3).
Table 3
Association between socio-demographic and clinical characteristics of the participants with presence or absence of 
malaria parasitaemia
Variable Positive parasitaemia Negative parasitaemia p-value
Sex Male 117 (83.6%) 23 (16.4%) 0.4281
Female 82 (79.6%) 21 (20.4%)
Caretaker Parent 168(85.7%) 28(14.3) 0.0211
Grandparent 9 (75%) 3(25)
Others 19(65.5%) 10(34.5)
WHO HIV stage Stage 1 75(82.4%) 16 (17.6%) 0.7341
Stage 2 85 (81.7%) 19(18.3%)
Stage 3and 4 34(87.2%) 5 (12.8%)
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Figure 2
Malaria parasitaemia status by WHO clinical staging of HIV disease
The children with malaria parasitaemia were older, had higher mean weight, had a higher mean absolute 
CD4 count, and had a higher mean temperature, and a higher mean respiratory rate but all these associations 
were	not	statistically	significant	(Table	4).
Table 4
Malaria parasitaemia status versus means of clinical and demographic characteristics of participants
Variable Mean for positive 
parasitaemia(s.d)
Mean for negative 
parasitaemia(s.d)
P-value
Age (years) 5.52(2.68) 5.51 (2.94) 0.9745
Weight in kg 19.45 (7.39) 18.44 (18.44) 0.5782
CD4 absolute 234.9 (1372.1) 112.39 (24.78) 0.4993
Temperature 0C 38.52 (0.44) 38.41 (0.46) 0.2090
Respiratory rate/min 38.04 (8.19) 37.22 (9.04) 0.4491
Pulse rate /minute 108.79 (16.46) 112.39 (24.78) 0.8945
Fever was found to have a positive predictive value 
of 81.9% for malaria parasitaemia among these febrile 
HIV infected children. 
DISCUSSION
In our study there was a high male preponderance 
of the participants with a male to female ratio of 
1.35:1. This is similar to a study conducted in Nigeria 
where they found a male /female ratio of 1.43:1 (12). 
The age distribution was almost equal with a slight 
shift to the older age group with a mean age of 5.53 
years. This was unlike the Nigeria study where they 
found a high number of febrile children among 
the HIV population to be more in the age group of 
less	 than	 two	 years	 (12).	 Our	 findings	 somewhat	
supports the shifting epidemiology of febrile illness 
among children in malaria endemic areas towards 
the older children. This has been attributed to the 
extensive campaign on malaria control by the roll 
back malaria team. Some of the strategies focus mainly 
on	the	under	five	year	olds	and	pregnant	women,	
an example is the use of mosquito nets. This is a 
worrying trend that may lead to a loss in the already 
achieved gains in malaria control. Considering that 
these are HIV infected children and as we know the 
natural history of disease, we are most likely having 
lower immunity among the older children compared 
to the younger and therefore more prone to malaria 
and other opportunistic infections that will give 
you	 febrile	 illness.	A	 recent	 study	 in	 Kilifi	 Kenya	
suggests that among febrile children admitted with 
severe malaria those infected with HIV were older 
than those were not infected (median 38 months and 
19 months respectively). Also the older children had 
higher peripheral parasite density. However, there 
was no relationship between HIV infection and severe 
malaria among the infants hence suggesting stunting 
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age related acquisition of immunity to malaria among 
the HIV infected children (13).
 Most of the children recruited had their primary 
caretaker being the parents (81.2 %) followed by 
grandparents.	 This	 is	 similar	 to	 the	 findings	 by	
Nyandiko et al who found an orphan hood prevalence 
of 10% in a cohort of HIV infected children in western 
Kenya	 (14).	 It	 was	 also	 a	 surprising	 finding	 that	
most of the children with malaria parasitaemia were 
those whose primary caretakers were the parents. 
It	 is	expected	that	worse	outcomes	or	findings	are	
associated with other caretakers other than the 
parents. Nyandiko et al in western Kenya found 
that those with severe malnutrition were orphans 
(14). However the health seeking behaviour may be 
different	for	the	different	caretakers.	It	 is	expected	
that parents will seek more prompt health care and 
in health facilities while others will go for over the 
counter medications and therefore may get away 
without being seen in a health facility. It has also 
been reported in some studies that people tend to 
seek health care from the community level providers 
which are their areas of proximity especially if their 
economic status is poor (15).
 The prevalence of malaria parasitaemia in this 
population of febrile HIV infected children was found 
to be quite high at 81.9%. This is much higher than 
in the general population of the area (Bungoma East 
district) which currently stands at 44.9% (16).However 
our population being a hospital based study may 
have been biased since these are sick children and 
are HIV infected. Imade et.al showed similar high 
prevalence	 in	 children	 below	 five	 years	 infected	
with HIV of up to76% in Nigeria (17). The number of 
fever episodes attributable to parasitaemia however 
cannot be determined from this study considering 
the study design. In another study in Nigeria a 65.8 
% prevalence of parasitaemia was reported among 
febrile children and fever was reported to be highly 
predictive of malaria (18). It is necessary to conduct a 
cohort study to document this. It is also well known 
that not all parasitaemia episodes will result in clinical 
disease.
 High asymptomatic parasitaemia have been 
reported in several studies hence the fever may be due 
to other bacterial infections or even drug reaction (19). 
Other causes of fever will include bacteraemia,urinary 
tract infections, and pneumonia with increased risk 
of serious disease in the more immunosuppressed 
(20). Some drugs used by the HIV infected children 
(Abacavir) have occasionally been reported to cause 
hypersensitivity that manifests with fever among 
other symptoms (21). Not all fevers equal infection. 
Fever is therefore a diagnostic challenge to the 
emergency	physician;	differential	diagnosis	is	broad	
especially among HIV infected children in a malaria 
endemic area. Fever is a common presentation to the 
clinic among the HIV infected children. Nyandiko et 
al in his study in western Kenya reported that 15%of 
the children presented with fever at enrolment (14).
	 No	differences	were	noted	between	the	clinical	
characteristic of those with parasitaemia and those 
without parasitaemia. Clinical presentation of malaria 
is	non-	specific	and	hence	the	diagnostic	dilemma	of	
presumptive diagnosis.
 CD4 count is one of the best predictors of the risk 
of an opportunistic infection. In our study we found 
the contrary that the meanCD4 count was higher 
among the children who had a positive parasitaemia 
as compared to those with negative parasitaemia 
(234.9 and 112.4 respectively). This was contrary to 
some studies in Malawi where incidence of clinical 
malaria episodes was higher in participants with 
CD4 cell count of less than 200 cells /mm3 than in 
those with a CD4 count of >75. Also higher density 
parasitaemia in patients with low CD4 count. This 
is however in adults and also varies on whether the 
patient is on ARVs or not. This trend was preserved 
even	when	more	specific	definitions	of	malaria	were	
made (22). This however was not the case with the 
WHO staging where we found more of the febrile 
children to be in stage 3 and 4 and more parasitaemia 
frequency in the same advanced stages. It is good to 
note that the CD 4 count used in our case was the 
latest CD4 usually done six monthly in the clinic. 
This may have changed with time especially if the 
child had already been started on ARVs. The CD4 
percentage was not available for all the children 
hence the absolute values were used. For the WHO 
staging the research assistants staged the children 
at	the	point	of	enrolment	hence	it	reflects	the	actual	
stage	at	enrolment.CD4	count	is	also	influenced	by	
the disease state, for example, acute illness. 
 Most of the patients seen (97.1%) were on 
cotrimoxale	 (septrin)	 prophylaxis.	 This	 confirms	
the widespread scaling up of cotrimoxazole use as 
recommended by WHO. In the year 2007,in western 
Kenya only 25 % of the HIV infected children were on 
cotrimoxazole (14).Several studies previously have 
suggested that cotrimoxazole prophylaxis yields a 
reduction in malaria episodes though no reduction in 
the incidence of severe malaria. A study by Sandison 
et al in Uganda yielded a 39 % reduction in malaria 
incidence. In another study cotrimoxazole was also 
associated	with	 an	 83%	protective	 efficacy	 (9,	 10).
We would thus have expected probably a lower 
prevalence of malaria parasitaemia.   It is known 
that in the setting that this study was conducted 
that there is a high prevalence of malaria resistance 
to anti-folates however it has been shown that even 
in areas of high anti-folate resistance the protective 
effect	of	cotrimoxazole		exists.	In	a	study	in	Uganda	a	
group of HIV infected population was found to have 
a high mutation dhfr 164l which is highly associated 
with anti-folates resistance and yet the cotrimoxazole 
yield	significant	protection	(9,	10).	Some	of	the	anti-
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retroviral drugs are also known to inhibit CYP 344 
pathway involved in Lumefantrine metabolism 
hence causing high levels of lumefantrine which 
provides	 a	 prolonged	 post	 treatment	 effect	 hence	
reducing subsequent episodes. Most of the children 
usually have received anti-malaria (artemether /
lumefantrine) drugs before coming to a level IV 
facility. Some though not documented in this study 
are on ritonavir hence we expected a lower level of 
parasitaemia. However we are unable to proceed 
with this argument due to limiting study design. 
We	 did	 not	 have	 sufficient	 numbers	 of	 patients	
not on cotrimoxazole to act as a control and hence 
make comparisons. Such a study would not be 
possible due to ethical reasons as cotrimoxazole has 
already been proven to provide protection against 
other opportunistic infections and hence cannot be 
withheld from the patient.
In conclusion, the frequency of malaria parasitaemia 
among HIV infected febrile children is still high 
regardless of the aggressive control methods being 
instituted. It was noted that those with malaria 
parasitaemia had a higher CD4 count. It is possible 
that most of the malaria we are seeing are carrier 
asymptomatic states and hence need to look for other 
possible causes of fever. Cotrimoxazol eprophylaxis 
uptake rate in the study population was quite high 
but still the parasitaemia rate remained high. There 
is an age shift towards the older children for malaria 
parasitaemia that requires urgent attention before the 
already made gains are lost.
RECOMMENDATION
Further studies need to be carried out to ascertain 
the fever that is attributable to malaria.
 Studies require to know whether the wide 
spread use of septrin is contributing to high malaria 
prevalence by causing anti-folates resistance. The 
anti-folates anti-malarial are still being used by many 
of our primary providers before the patient gets to 
the health facility.
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